Cameroon vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Antiretroviral therapy coverage

Cameroon
88.0%
in 2024
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
26.5%
in 2024
Cameroon rank
23rd
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank
22nd

Antiretroviral therapy coverage over time

  • Cameroon
  • Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
020406080200020122024

How they compare

Cameroon currently reports 88.0% against 26.5% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), a difference of 61.5%.

That makes Cameroon's figure about 3.3 times Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)'s.

The two have swapped places 1 time across 25 shared years of data; in 2000 it was Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ahead.

Cameroon ranks 23rd and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 22nd of 143 countries.

Cameroon has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Cameroon Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) Difference Ahead
2000s 4.3% 3.4% 0.9% Cameroon
2010s 32.7% 12.8% 19.9% Cameroon
2020s 78.4% 23.1% 55.3% Cameroon

Averages of every year both report within each decade.

Frequently asked questions

Which has higher antiretroviral therapy coverage, Cameroon or Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
Cameroon, at 88.0% against 26.5% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) as of 2024.
What is the difference in antiretroviral therapy coverage between Cameroon and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
61.5%, with Cameroon ahead.
How many years of comparable data are there for Cameroon and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
25 years are reported by both, from 2000 to 2024.
How do Cameroon and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank globally for antiretroviral therapy coverage?
Cameroon ranks 23rd and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 22nd of 143 countries.
Where does this data come from?
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Cameroon vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Antiretroviral therapy coverage. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 19 September 2026, from https://health.statizoid.com/compare/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/cameroon/middle-east-north-africa-afghanistan-and-pakistan-ida-and-ibrd/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/cameroon/middle-east-north-africa-afghanistan-and-pakistan-ida-and-ibrd/">Cameroon vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Antiretroviral therapy coverage</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage (% of people living with HIV)
Unit
% of people living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
166 places, 4,061 data points, 2000–2024
Last refreshed

Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.